Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy?-Reference-Cited by-同舟云学术

Ileal and colonic Crohn's disease: Does location makes a difference in therapy efficacy?

Published:2022 Issue: Volume:3 Page:100097
ISSN:2590-2571
Container-title:Current Research in Pharmacology and Drug Discovery
language:en
Short-container-title:Current Research in Pharmacology and Drug Discovery

Author:

Atreya Raja^ORCID,Bojarski Christian,Kühl Anja A.,Trajanoski Zlatko,Neurath Markus F.,Siegmund Britta

Publisher

Elsevier BV

Subject

Animal Science and Zoology,Ecology, Evolution, Behavior and Systematics

Reference55 articles.

1. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved;Afzal;Dig. Dis. Sci.,2005

2. Clinical, endoscopic and safety placebo rates in induction and maintenance trials of Crohn's disease: meta-analysis of Randomised controlled trials;Almradi;J. Crohns Colitis,2021

3. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis;Arijs;Gut,2009

4. Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease;Arijs;Inflamm. Bowel Dis.,2010

5. An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease;Arnott;Aliment. Pharmacol. Ther.,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discordant Effects of Janus Kinase Inhibition Ex Vivo on Inflammatory Responses in Colonic Compared to Ileal Mucosa;Journal of Crohn's and Colitis;2024-07-29

2. Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn’s Disease: A Post-hoc Analysis of the FITZROY Trial;Journal of Crohn's and Colitis;2024-07-20

3. Real-world clinical effectiveness of ustekinumab in the treatment of Crohn’s disease in the East Midlands UK;Frontline Gastroenterology;2024-06-14

4. Serum proteome signatures associated with ileal and colonic ulcers in Crohn's disease;Journal of Proteomics;2024-06

5. Cyclophosphamide-free Mobilisation Increases Safety While Preserving the Efficacy of Autologous Haematopoietic Stem Cell Transplantation in Refractory Crohn’s Disease Patients;Journal of Crohn's and Colitis;2024-05-17